Common Equity: The sum of all common equity items.
Kronos Bio, Inc. (KRON) had Common Equity of $159.08M for the most recently reported fiscal quarter, ending 2023-12-31.
Income Statement Financials | |
$2.29M |
|
$-25.32M |
|
-- |
|
$2.29M |
|
$29.63M |
|
$-27.34M |
|
$2.02M |
|
$-25.32M |
|
$-25.32M |
|
$-25.32M |
|
$-25.32M |
|
$-25.32M |
|
$-25.32M |
|
$-27.34M |
|
$-25.19M |
|
57.74M |
|
57.74M |
|
$-0.43 |
|
$-0.43 |
|
Balance Sheet Financials | |
$178.78M |
|
$10.25M |
|
$34.50M |
|
$213.28M |
|
$24.70M |
|
-- |
|
$29.51M |
|
$54.20M |
|
Common Equity |
$159.08M |
$159.08M |
|
$159.08M |
|
58.95M |
|
Cash Flow Statement Financials | |
$-78.58M |
|
$66.37M |
|
$0.57M |
|
$78.00M |
|
$66.35M |
|
$-11.65M |
|
$24.98M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
7.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1196.15% |
|
-1196.15% |
|
-- |
|
-1107.61% |
|
-1107.61% |
|
$-79.26M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-15.92% |
|
-15.92% |
|
-11.87% |
|
-15.92% |
|
$2.70 |
|
$-1.37 |
|
$-1.36 |